FDA
-
-
-
-
-
-
-
Eyegate Pharma (EYEG) Announces Acquisition of Panoptes Pharma
-
-
-
-
-
-
-
Eyegate Pharma (EYEG) to Move Forward on PE Pivotal Study Following Feedback from FDA Meeting
-
-
-
-
-
-
-
EyeGate Pharma Announces Positive Topline Data in Follow-on Dry Eye Pilot Study
-
-
-
-
-
-
-
EyeGate Pharma Receives $1.9 Million from Exercised Warrants
-
-
-
-
-
-
-
Eyegate Pharma (EYEG) Reports Complete Randomization in Pivotal Study Using the Ocular Bandage Gel Eye Drop
-
-
-
-
-
-
-
EyeGate Pharma Announces Reverse Stock Split Effective August 30, 2019
-
-
-
-
-
-
-
EyeGate Pharma Reports First Quarter 2019 Financial Results and Provides Business Update
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

